Neuroprotective Agents with Therapeutic Potential for COVID-19 [PDF]
Biomolecules, 2023 COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID ...
César A. Zaa +4 more
doaj +4 more sources
Quinones as Neuroprotective Agents [PDF]
Antioxidants, 2023 Quinones can in principle be viewed as a double-edged sword in the treatment of neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic due to covalent and redox modification of biomolecules.
Ángel Cores +4 more
doaj +2 more sources
Fiscalin Derivatives as Potential Neuroprotective Agents [PDF]
Pharmaceutics, 2022 Neurodegenerative diseases (ND) share common molecular/cellular mechanisms that contribute to their progression and pathogenesis. In this sense, we are here proposing new neuroprotection strategies by using marine-derived compounds as fiscalins.
Sandra Barreiro +6 more
doaj +2 more sources
Carbon nanotubes as neuroprotective agents [PDF]
Exploration of Neuroprotective TherapyCarbon nanotubes, an emerging class of carbon nanomaterials, possess tremendous potential for application in biotechnology and biomedicine particularly in neurological disorders.
Daisy L. Wilson +2 more
doaj +2 more sources
Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis [PDF]
Frontiers in NeuroscienceBackgroundIschemic stroke is the second leading cause of death and the third leading cause of combined disability and mortality globally. While reperfusion therapies play a critical role in the management of acute ischemic stroke (AIS), their ...
Yuchen Wang +6 more
doaj +2 more sources
Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents. [PDF]
Antioxidants (Basel), 2023 Juric M +4 more
europepmc +3 more sources
Preface: 2022 International Conference on Neuroprotective Agents. [PDF]
Exp Biol Med (Maywood), 2023 Slikker W, Patterson TA, Andrews RJ.
europepmc +3 more sources
Mining and evaluation of security alert signals of neuroprotective agents based on the Jinan adverse event reporting system database: a retrospective study [PDF]
Frontiers in PharmacologyBackgroundPharmacologic agents with proposed neuroprotective properties are increasingly investigated; however, limited regulation and heterogeneous evidence raise concerns about their safety profiles. To establish a foundation for its safe clinical use,
Yu-yao Guan +4 more
doaj +2 more sources
Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation. [PDF]
Front Chem, 2022 Wang Y, Qian S, Zhao F, Wang Y, Li J.
europepmc +2 more sources
2024 international conference on neuroprotective agents conference proceedings [PDF]
Experimental Biology and MedicineWilliam Slikker +3 more
doaj +2 more sources